₹83.25
(Market cap
₹1,732 Cr
Revenue (TTM)
₹252 Cr
P/E Ratio
56.8
P/B Ratio
5.3
Div. Yield
0 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹30 Cr
-
ROE
6.5 %
-
ROCE
8.4 %
-
Industry P/E
31.55
-
EV/EBITDA
25.1
-
Debt to Equity
0.1
-
Book Value
₹145.8
-
EPS
₹13.7
-
Face value
10
-
Shares outstanding
22,249,910
10 Years Aggregate
CFO
₹200.76 Cr
EBITDA
₹240.80 Cr
Net Profit
₹93.63 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sakar Healthcare
| 90.6 | 31.4 | 61.2 | 147.7 | 48.8 | 39.8 | -- |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Sakar Healthcare
| 35.7 | -27.6 | 78.4 | 37.9 | 65.6 | 48.3 | 10.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sakar Healthcare
|
780.0 | 1,731.7 | 251.7 | 30.5 | 18.0 | 9.7 | 56.8 | 5.3 |
| 3,214.1 | 40,194.3 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38.1 | 8.9 | |
| 8,513.5 | 21,210.6 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.6 | 25.5 | |
| 1,986.1 | 15,095.9 | 2,187.2 | 649.7 | 31.5 | 19 | 23.5 | 4.2 | |
| 1,820.2 | 11,132.1 | 1,196.4 | 149.4 | -- | 27.5 | 60.1 | 14.9 | |
| 1,340.8 | 18,565.2 | 3,078.2 | 469.4 | 26.4 | 14.9 | 43 | 5.1 | |
| 2,125.3 | 34,148.4 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.1 | 8.2 | |
| 4,859.3 | 22,307.5 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.9 | 5.3 | |
| 476.2 | 9,265.7 | 1,432.0 | 149.0 | 19.1 | 7.9 | 61.8 | 3.7 | |
| 1,151.4 | 10,389.7 | 4,725.6 | 528.7 | 14.9 | 20.7 | 20.3 | 3.5 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Micro caps with a bullish sentiment
3 min read•By Danish Khanna and Udhayaprakash
About Sakar Healthcare
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in... ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India. Read more
-
Incorporated
2004
-
Chairman
Sanjay S Shah
-
Managing Director
Sanjay S Shah
-
Headquarters
Ahmedabad Dist, Gujarat
-
Website
Looking for more details about Sakar Healthcare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Announcements
View AnnouncementsFAQs for Sakar Healthcare
What is the current share price of Sakar Healthcare Ltd Today?
The share price of Sakar Healthcare Ltd is ₹779.95 (NSE) as of 18-May-2026 IST. Sakar Healthcare Ltd has given a return of 48.78% in the last 3 years.
What is the current PB & PE ratio of Sakar Healthcare Ltd?
The P/E ratio of Sakar Healthcare Ltd is 56.81 times as on 18-May-2026, a 80 premium to its peers’ median range of 31.55 times.
The P/B ratio of Sakar Healthcare Ltd is 5.34 times as on 18-May-2026, a 15 premium to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
26.55
|
1.64
|
|
2024
|
68.64
|
3.11
|
|
2023
|
29.94
|
2.20
|
|
2022
|
15.24
|
1.82
|
|
2021
|
16.54
|
1.79
|
What is the 52 Week High and Low of Sakar Healthcare Ltd?
The 52-week high and low of Sakar Healthcare Ltd are Rs 794.00 and Rs 306.00 as of 18-May-2026.
What is the market cap of Sakar Healthcare Ltd?
Sakar Healthcare Ltd has a market capitalisation of ₹ 1,732 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sakar Healthcare Ltd?
Before investing in Sakar Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.